Proxima
Reprograming protein-protein interactions to unlock new small-molecule therapies for cancer, autoimmune disorders, and other hard-to-treat diseases
Life science companies — whether they make drugs, medical devices, or digital applications — need quality management systems to track development and production issues and meet regulatory requirements. But many companies rely on an inefficient jumble of software tools. Enzyme’s cloud-based QMS intuitively automates document management, change control, training, design control, compliance, risk management, supplier management, customer complaints, and more. With Enzyme eQMS, users can streamline their quality control workflows and generate FDA-ready documentation at the click of a button.
Reprograming protein-protein interactions to unlock new small-molecule therapies for cancer, autoimmune disorders, and other hard-to-treat diseases
Transforming biology from a science into engineering
Using AI models trained on digital pathology images to help oncologists make smarter cancer treatment decisions
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing